News & Press Release

Sisram Medical (1696.HK) and Fosun Industrial Enter into a Sublicense Agreement for the Commercialization of DaxibotulinumtoxinA (RT002) Injectable

Sisram Medical Group expects to record significant increases of more than 73% in its revenue and more than 190% in its profits for the First 6 Months of 2021, as compared to that for the corresponding period in 2020.

Sisram Medical Expands its Dental Business Line with Proposed Acquisition of Shanghai Foshion Medical System, a Leading Dental Equipment Sales & Marketing Platform in China

HONG KONG, April 12, 2021 – Sisram Medical Ltd (“Sisram” or “the Company”) (Hong Kong: 1696), an operational holding company specializing in medical aesthetics technology for ..

Total revenue for the Reporting Period was US$162.1 million, while the average revenue in the second half of 2020 exceeded 2.6% YOY. ..

Alma, a Sisram Medical Company, Wins 2020 Innovative Treatment of the Year Award from MyFaceMyBody

Alma, a Sisram Medical Company, Introduces a Landmark New Approach in the Indian Anti-ageing Treatments Market – PROFHILO

Alma Launches Alma Hybrid^TM, the first and only device of its kind – exclusively combining 3 powerful energy sources to deliver unparalleled results

Sisram Medical Expands its APAC Operation, Opening a New Regional Office in Tianjin, China

Sisram Medical Ltd Announces Its Interim Results for the First Half of 2020, Showing Operational Resilience While Protecting its Assets and Ensuring Future Prosperity Amid COVID-19 Pandemic

Sisram Medical Ltd Announces 2019 Annual Results,
Continuing Strong Revenue Growth to Exceed Industry CAGR

Alma, a Sisram Medical Company, Launches Breakthrough ClearSkin PRO
Doubling the power of previous solutions, ClearSkin PRO provides visibly younger looking skin

Alma, a Sisram Medical Company, Receives Excellence Award for “Outstanding Business Performance in Japan”

Alma, a Sisram Medical Company, Wins Two 2019 Global Aesthetic Awards by MyFaceMyBody

Sisram Medical Ltd Announces Its Interim Results for the First Half of 2019, Showcasing 9.3% Revenue Growth Driven by Consumer-Centric Approach

Alma, a Sisram Medical Company, Celebrates its Platinum Anniversary – 20 Years of Global Leadership

Alma, a Sisram Medical company, announces launch of BeautiFill^TM, the first laser-based platform to produce high quality autologous fat for holistic body and face contouring

Continuing Solid and Balanced Growth

Sisram Medical Expends its Europe Operation, Opening a New Continental Service Facility in Germany

Sisram Medical Adds Chinese Stock Trading Name to Better Connect with Asia-Pacific Market and Explore Business Expansion

Alma, a Sisram Medical Company, Awarded MDSAP Certification.

Alma, a Sisram Medical Company, Announces the Opening of a Direct Operation in Israel Following the Acquisition of its Israeli Distributor

Alma, a Sisram Medical Company, Launches RESHAPE, a Hybrid Body & Face Contouring platform

Sisram Launches PICO CLEAR, Marking a New Era in Dermatology
PICO CLEAR’s superior ultra-short picosecond technology offers optimal results, in fewer treatments

Sisram Announces Its Interim Results for the First Half of 2018, Demonstrating Impressive and Consistent Growth

Sisram Lays out a Post-IPO Vision of Becoming Gobal MedTech Leader

Sisram Med Presents its Best Annual Reports to Date

FDA clearance on its award-winning Soprano ICE Platinum

ALMA BEAUTY SPADEEP Globally Launched After Receiving Outstanding Feedbacks in Japanese Market

Increase in Shareholding by Controlling Shareholder and CEO